Use of gabapentin to reduce chronic neuropathic pain in Fabry disease

The effect of the anticonvulsant gabapentin on neuropathic pain was studied in six male patients with Fabry disease, aged 15-45 years. After 4 weeks of treatment, pain, as measured using the Brief Pain Inventory, was decreased compared with baseline. Treatment was generally well tolerated. This stud...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ries, Markus (VerfasserIn) , Mengel, Eugen (VerfasserIn) , Kutschke, G. (VerfasserIn) , Kim, K. S. (VerfasserIn) , Birklein, F. (VerfasserIn) , Krummenauer, Frank (VerfasserIn) , Beck, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 01 June 2003
In: Journal of inherited metabolic disease
Year: 2003, Jahrgang: 26, Heft: 4, Pages: 413-414
ISSN:1573-2665
DOI:10.1023/A:1025127723729
Online-Zugang:Verlag, Volltext: https://doi.org/10.1023/A:1025127723729
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1023/A%3A1025127723729
Volltext
Verfasserangaben:M. Ries, E. Mengel, G. Kutschke, K.S. Kim, F. Birklein, F. Krummenauer and M. Beck

MARC

LEADER 00000caa a2200000 c 4500
001 1665840978
003 DE-627
005 20230427160250.0
007 cr uuu---uuuuu
008 190516s2003 xx |||||o 00| ||eng c
024 7 |a 10.1023/A:1025127723729  |2 doi 
035 |a (DE-627)1665840978 
035 |a (DE-599)KXP1665840978 
035 |a (OCoLC)1341224932 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ries, Markus  |d 1971-  |e VerfasserIn  |0 (DE-588)136385338  |0 (DE-627)582068479  |0 (DE-576)300993358  |4 aut 
245 1 0 |a Use of gabapentin to reduce chronic neuropathic pain in Fabry disease  |c M. Ries, E. Mengel, G. Kutschke, K.S. Kim, F. Birklein, F. Krummenauer and M. Beck 
264 1 |c 01 June 2003 
300 |a 2 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 16.05.2019 
520 |a The effect of the anticonvulsant gabapentin on neuropathic pain was studied in six male patients with Fabry disease, aged 15-45 years. After 4 weeks of treatment, pain, as measured using the Brief Pain Inventory, was decreased compared with baseline. Treatment was generally well tolerated. This study indicates that gabapentin should be considered as a treatment option for the neuropathic pain of Fabry disease. 
700 1 |a Mengel, Eugen  |d 1963-  |e VerfasserIn  |0 (DE-588)135623901  |0 (DE-627)56860427X  |0 (DE-576)300550545  |4 aut 
700 1 |a Kutschke, G.  |e VerfasserIn  |4 aut 
700 1 |a Kim, K. S.  |e VerfasserIn  |4 aut 
700 1 |a Birklein, F.  |e VerfasserIn  |4 aut 
700 1 |a Krummenauer, Frank  |d 1969-  |e VerfasserIn  |0 (DE-588)172983916  |0 (DE-627)697909778  |0 (DE-576)13383736X  |4 aut 
700 1 |a Beck, Michael  |d 1947-2022  |e VerfasserIn  |0 (DE-588)132550423  |0 (DE-627)523640226  |0 (DE-576)189101768  |4 aut 
773 0 8 |i Enthalten in  |t Journal of inherited metabolic disease  |d Hoboken, NJ : Wiley, 1978  |g 26(2003), 4, Seite 413-414  |h Online-Ressource  |w (DE-627)320457753  |w (DE-600)2006875-X  |w (DE-576)105704652  |x 1573-2665  |7 nnas  |a Use of gabapentin to reduce chronic neuropathic pain in Fabry disease 
773 1 8 |g volume:26  |g year:2003  |g number:4  |g pages:413-414  |g extent:2  |a Use of gabapentin to reduce chronic neuropathic pain in Fabry disease 
856 4 0 |u https://doi.org/10.1023/A:1025127723729  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1023/A%3A1025127723729  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190516 
993 |a Article 
994 |a 2003 
998 |g 136385338  |a Ries, Markus  |m 136385338:Ries, Markus  |p 1  |x j 
999 |a KXP-PPN1665840978  |e 3476625427 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 16.05.2019"],"recId":"1665840978","id":{"doi":["10.1023/A:1025127723729"],"eki":["1665840978"]},"title":[{"title":"Use of gabapentin to reduce chronic neuropathic pain in Fabry disease","title_sort":"Use of gabapentin to reduce chronic neuropathic pain in Fabry disease"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"01 June 2003","dateIssuedKey":"2003"}],"language":["eng"],"relHost":[{"id":{"eki":["320457753"],"doi":["10.1002/(ISSN)1573-2665"],"zdb":["2006875-X"],"issn":["1573-2665"]},"title":[{"subtitle":"JIMD ; official journal of the Society for the Study of Inborn Errors of Metabolism","title":"Journal of inherited metabolic disease","title_sort":"Journal of inherited metabolic disease"}],"disp":"Use of gabapentin to reduce chronic neuropathic pain in Fabry diseaseJournal of inherited metabolic disease","note":["Gesehen am 11.03.20","Ungezählte Beil.: Suppl"],"part":{"pages":"413-414","extent":"2","year":"2003","volume":"26","issue":"4","text":"26(2003), 4, Seite 413-414"},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedKey":"1978","publisherPlace":"Hoboken, NJ ; Dordrecht [u.a.] ; Dordrecht [u.a.]","dateIssuedDisp":"1978-","publisher":"Wiley ; Kluwer ; Springer Science + Business Media B.V"}],"titleAlt":[{"title":"JIMD"}],"pubHistory":["1.1978 -"],"recId":"320457753"}],"person":[{"display":"Ries, Markus","role":"aut","given":"Markus","roleDisplay":"VerfasserIn","family":"Ries"},{"family":"Mengel","roleDisplay":"VerfasserIn","role":"aut","display":"Mengel, Eugen","given":"Eugen"},{"display":"Kutschke, G.","role":"aut","given":"G.","family":"Kutschke","roleDisplay":"VerfasserIn"},{"family":"Kim","roleDisplay":"VerfasserIn","display":"Kim, K. S.","role":"aut","given":"K. S."},{"role":"aut","display":"Birklein, F.","given":"F.","family":"Birklein","roleDisplay":"VerfasserIn"},{"family":"Krummenauer","roleDisplay":"VerfasserIn","role":"aut","display":"Krummenauer, Frank","given":"Frank"},{"given":"Michael","role":"aut","display":"Beck, Michael","roleDisplay":"VerfasserIn","family":"Beck"}],"name":{"displayForm":["M. Ries, E. Mengel, G. Kutschke, K.S. Kim, F. Birklein, F. Krummenauer and M. Beck"]},"physDesc":[{"extent":"2 S."}]} 
SRT |a RIESMARKUSUSEOFGABAP0120